Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,350.00
+100.00 (1.90%)
Nov 18, 2024, 3:19 PM KST

Sinsin Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Operating Revenue
105,246102,58691,92674,00867,12967,855
Upgrade
Other Revenue
-0-0--0--
Upgrade
Revenue
105,246102,58691,92674,00867,12967,855
Upgrade
Revenue Growth (YoY)
6.96%11.60%24.21%10.25%-1.07%6.49%
Upgrade
Cost of Revenue
70,48369,27461,70652,31848,70844,386
Upgrade
Gross Profit
34,76433,31230,22021,68918,42123,468
Upgrade
Selling, General & Admin
26,93525,72623,77021,27720,96719,357
Upgrade
Research & Development
558.7488.0389.9709.07785.21575.91
Upgrade
Other Operating Expenses
230.26220.94228.42220.21276.09182.76
Upgrade
Operating Expenses
28,70527,30824,79423,03222,59121,139
Upgrade
Operating Income
6,0596,0045,426-1,343-4,1702,329
Upgrade
Interest Expense
-2,032-1,937-1,481-963.24-893.62-247.61
Upgrade
Interest & Investment Income
38.2840.348.3215.5551.12
Upgrade
Currency Exchange Gain (Loss)
188.0219.14277.35242.67-201.51117.02
Upgrade
Other Non Operating Income (Expenses)
-16.59-131.88-222.32331.37398.98177.84
Upgrade
EBT Excluding Unusual Items
4,2363,9954,009-1,730-4,8502,427
Upgrade
Gain (Loss) on Sale of Investments
-----0.27
Upgrade
Gain (Loss) on Sale of Assets
-0-038.550.734,581-
Upgrade
Asset Writedown
----18.16--297.1
Upgrade
Pretax Income
4,2363,9954,047-1,747-269.322,131
Upgrade
Income Tax Expense
248.4-651.57-308.12-297.73-470.61106.83
Upgrade
Earnings From Continuing Operations
3,9884,6464,355-1,449201.292,024
Upgrade
Minority Interest in Earnings
60.7833.7759.32-26.47161.37113.86
Upgrade
Net Income
4,0494,6804,415-1,476362.662,138
Upgrade
Net Income to Common
4,0494,6804,415-1,476362.662,138
Upgrade
Net Income Growth
-22.86%6.01%---83.03%-26.19%
Upgrade
Shares Outstanding (Basic)
151515151515
Upgrade
Shares Outstanding (Diluted)
151515151515
Upgrade
EPS (Basic)
266.88308.49291.00-97.2923.91140.90
Upgrade
EPS (Diluted)
266.49308.49291.00-97.2923.91140.90
Upgrade
EPS Growth
-22.97%6.01%---83.03%-26.19%
Upgrade
Free Cash Flow
519.87-1,0814,553-2,659-10,104-25,010
Upgrade
Free Cash Flow Per Share
34.27-71.27300.15-175.28-666.04-1648.61
Upgrade
Dividend Per Share
60.00060.000---28.000
Upgrade
Dividend Growth
------15.15%
Upgrade
Gross Margin
33.03%32.47%32.87%29.31%27.44%34.59%
Upgrade
Operating Margin
5.76%5.85%5.90%-1.81%-6.21%3.43%
Upgrade
Profit Margin
3.85%4.56%4.80%-1.99%0.54%3.15%
Upgrade
Free Cash Flow Margin
0.49%-1.05%4.95%-3.59%-15.05%-36.86%
Upgrade
EBITDA
10,2019,9419,1842,329-1,5863,500
Upgrade
EBITDA Margin
9.69%9.69%9.99%3.15%-2.36%5.16%
Upgrade
D&A For EBITDA
4,1423,9373,7583,6722,5841,171
Upgrade
EBIT
6,0596,0045,426-1,343-4,1702,329
Upgrade
EBIT Margin
5.76%5.85%5.90%-1.81%-6.21%3.43%
Upgrade
Effective Tax Rate
5.86%----5.01%
Upgrade
Advertising Expenses
-4,3404,1883,4173,2672,872
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.